Navigation Links
syndicate in Medical News

King Features Syndicate and Changing Times Vitamins Sign Licensing Agreement for Popeye(R) the Sailor Man in the Water Drink Category.

SCOTTSDALE, Ariz., Nov. 19 /PRNewswire-FirstCall/ -- Changing Times Vitamins, Inc., (Pink Sheets: SGTB) announced today that they have signed a licensing agreement with King Features Syndicate, Division of Hearst Corporation, one of the nation's largest diversified media companies. The license giv...

The Providence Service Corporation Announces Credit Agreement Amendment With Its Lender Syndicate

Interest rate changed; Covenants reset for 2008 and 2009 TUCSON, Ariz., March 11 /PRNewswire-FirstCall/ -- The Providence Service Corporation (Nasdaq: PRSC ) today announced it has signed an amended credit agreement with its senior debt holders related to its $173 million senior term loan. ...

A syndicate formed to spruce up mental health

Ireland: With a motto to facilitate improvement in the area of mental health, many Irish groups have joined hands to garner acceptance from stakeholders //to petition the upliftment of mental health services. The Irish section of Amnesty International, Bodywhys, GROW, the Irish Advocacy Networ...

EANS-News: Alapis Announces its Share Capital Increase to Raise c. EUR 451.1 million

...ntiadis or in the open market. The Company was also informed that Dr.Lavrentiadis is a director of the general partner of Lamda Partners L.P. A syndicate of international firms composed of ABN AMRO, BofA Merrill Lynch, BNP PARIBAS, Deutsche Bank AG London Branch and Jefferies has agreed to subscribe or ...

Inverness Medical Innovations, Inc. Announces Offering of $150 Million of Senior Notes

... Department, or at 1-866-471-2526, or Wells Fargo Securities, LLC at 301 South College Street, Sixth Floor, Charlotte, NC 28202, Attention: High Yield syndicate or at 1-704-715-8324. This press release is neither an offer to sell nor a solicitation of an offer to buy the securities described herein, no...

Orexigen(R) Therapeutics Prices Public Offering of Common Stock

...means of a prospectus supplement and the accompanying prospectus, copies of which may be obtained, when available, from Leerink Swann LLC , Attention: syndicate Department, One Federal Street, 37th Fl., Boston, MA 02110 or by calling Leerink Swann LLC, toll free, at 1-800-808-7525, Ext. 4814. About O...

Orexigen(R) Therapeutics Announces Proposed Public Offering of Common Stock

...ble, copies of the prospectus supplement and the accompanying prospectus relating to this offering may be obtained from Leerink Swann LLC , Attention: syndicate Department, One Federal Street, 37th Fl., Boston, MA 02110 or by calling Leerink Swann LLC, toll free, at 1-800-808-7525, Ext. 4814. About O...

MultiNational Underwriters Is Now HCC Medical Insurance Services

...as adopted the HCC name to operate as HCC Medical Insurance Services (HCCMIS). HCCMIS underwrites on behalf of HCC Life Insurance Company and Lloyd's syndicate 4141. Since its inception as MultiNational Underwriters in 1998, MNU has been a recognized leader in the field of international medical insu...

New Day Pharmacy Receives $10.2 Million in Growth Capital

...July 8 /PRNewswire/ -- Nashville-based New Day Pharmacy is expected to see rapid growth after the infusion of $10.2 million in growth capital from a syndicate of institutional investors led by Council Ventures . The investment will allow New Day to offer its revolutionary virtual "in-house pharmacy" se...

Torchmark Prices Senior Notes Offering

... Markets, LLC c/o Wachovia Customer Information Center 1525 West W.T. Harris Boulevard Charlotte, North Carolina 28262-0675 Attention: syndicate Operations 1-800-326-5897 SunTrust Robinson Humphrey, Inc. 303 Peachtree Street, 24th Floor Mail Code: GA-ATLANTA-3947 Atlanta, G...
syndicate in Medical Technology

Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis

...h a special focus on retinal pathologies. Founded in May 2005, Fovea has raised euro 50.5m ($69m) in two financing rounds from a strong international syndicate of investors. Fovea has built a project portfolio including internal research programs on dry AMD, glaucoma (neuroprotection) and retinal dystrop...

Circassia's Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients

...th a proven track record in product development and commercialization. Having successfully completed two fundraising rounds the company is backed by a syndicate of world-class venture capital and institutional investors, including Imperial Innovations, Lansdowne Partners, Goldman Sachs and Invesco Perpetual. ...

DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round

...alized in the development of innovat0ive medicines in oncology, announces the successful closing of its Series A equity investment round. The investor syndicate led by SGAM SEFTI with two of the previous seed investors, Blue Medical Investments and G1J-Ile de France, is committed to invest 2.2 million EUR base...

Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology

... team with a proven track record in product development and commercialization, and having successfully completed two fundraising rounds is backed by a syndicate of world-class venture capital and institutional investors, including Imperial Innovations, Lansdowne Partners, Goldman Sachs and Invesco Perpetual. ...

Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology

... team with a proven track record in product development and commercialization, and having successfully completed two fundraising rounds is backed by a syndicate of world-class venture capital and institutional investors, including Imperial Innovations, Lansdowne Partners, Goldman Sachs and Invesco Perpetual. ...

Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial

...) family of tests that measure patient response to antiplatelet drugs, announced today that it has raised $28.8 million in its Series D financing. The syndicate was led by Arnerich Massena & Associates, Inc. and BBT Fund, L.P. Also participating in the round were previous investors: Essex Woodland Health Ventu...

Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa

...a has a highly experienced board and management team. Last December 2007, it raised EUR30M ($44M) in a Series B financing from a strong, international syndicate of new and existing investors led by Forbion Capital Partners (Naarden, The Netherlands). All existing institutional investors participated in the rou...
syndicate in Biological Technology

Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock

... or jurisdiction. Copies of the prospectus supplement and accompanying prospectus may be obtained, when available, from Leerink Swann LLC, Attention: syndicate Department, One Federal Street, 37(th) Floor, Boston, MA 02110 or by calling toll free, at 1-800-808-7525, Ext. 4814. About Idenix Ideni...

Sunesis Reports Financial Results for the Second Quarter 2009

...on, with no debt outstanding. "In the second quarter, we completed the initial closing of a tranched financing of up to $43.5 million with a syndicate of experienced life science investors. We also presented positive new data on all three of our Phase 2 voreloxin studies at ASCO," said Daniel Swisher...

Orexigen(R) Therapeutics Announces Full Exercise of Overallotment Option by Underwriters

... be made only by means of a prospectus supplement and the accompanying prospectus, copies of which may be obtained from Leerink Swann LLC , Attention: syndicate Department, One Federal Street, 37th Fl., Boston, MA 02110 or by calling Leerink Swann LLC, toll free, at 1-800-808-7525, Ext. 4814. About O...

Cappella Inc. Secures $17.3 Million Series C Investment

...pan is reassuring and will help to accelerate the company's marketing efforts of its device portfolio. Importantly, the continued participation of our syndicate partners, in particular ACT Venture Capital, in our common cause was a prerequisite to get the company to this exciting value inflection point." ...

Proteon Therapeutics Completes Second Closing of Equity Financing; Raises Total Series B to $50 million

...license under pre-agreed conditions. "We are very pleased and fortunate to add the outstanding firms of Bessemer and Devon Park to our existing syndicate of blue chip investors," said Timothy P. Noyes, President and CEO of Proteon. The initial closing of the Series B financing in March included n...

Beckman Coulter Prices $500 Million Senior Notes Offering

...lements may be obtained by calling Citigroup Global Markets Inc. toll-free at 1-877-858-5407, by mailing J.P. Morgan Securities Inc., Investment Grade syndicate Desk, 270 Park Ave, New York, NY 10017, or by mailing Morgan Stanley & Co. Incorporated, Prospectus Department, 1585 Broadway, New York, NY 1...

Lycera Closes $36 Million Series A Financing

...meet the needs of a sector of the healthcare market. Located in Michigan, EDF invests throughout the country and is proud of its ability to attract as syndicate members several of the nation's leading healthcare venture investors. The EDF portfolio includes companies developing medical devices, clinical diagn...

Marinus Pharmaceuticals Raises $20 Million in Series B Financing

...ndidate," said John Krayacich, president and CEO of Marinus Pharmaceuticals. "In light of this challenging environment, the continued support from our syndicate of premier life sciences investors validates our efforts, reinforces our accomplishments, and allows us to further advance this unique therapy which w...

Allegro Diagnostics Expands Board and Executive Team

...plied within the health care and life science industries. At the core of its strategy is a committed, hands-on approach to working with management and syndicate partners to build successful companies. Catalyst's disciplined investment process leverages both intellectual and financial capital to originate deals...

Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets

... LONDON, February 24 /PRNewswire/ -- - syndicate Comprises Leading Sector Investors Clarus Ventures, MVM Life Science Partne...tter medicines. The fact that Heptares has attracted such a strong investor syndicate and funding round so early in its development also shows how quickly this t...
Other Tags
(Date:9/23/2014)... Royal Sport Ultra Clean 100 is the ... of premium sports nutrition products. Its gluten free formula ... without artificial colors or dyes, fillers, added sugar and ... shelves at select GNC retailers, on GNC.com, and through ... a limited time special on its products. Customers can ...
(Date:9/23/2014)... ADOMANI, Inc. has announced that ... CEO. He is a 13-year veteran in the school, commercial ... of A-Z Bus Sales of Colton, California. While with A-Z ... their top line revenues, profit and market penetration by double ... diesel to all-electric or plug-in hybrid vehicle conversions. They ...
(Date:9/23/2014)... 23, 2014 Airbus Helicopters Inc. (AHI) ... honored as the 2014 Vision Zero Aviation Safety ... database, a free flight safety service the company ... Manager - Air Medical Specialist for Airbus Helicopters Inc., ... $10,000 check during the Air Medical Transport Conference Annual ...
(Date:9/23/2014)... issue of the European Journal of Cancer ... presented during the 1st EORTC Cancer Survivorship Summit held ... targeted therapeutics, and more personalized multimodal treatments has boosted ... a large and rapidly increasing number of cancer survivors. ... with a broad spectrum of late adverse treatment effects ...
(Date:9/23/2014)... a driving force behind many chronic diseases, especially ... inflammation caused by conditions such as viral hepatitis ... options. Now, scientists at Virginia Commonwealth University Massey ... in preclinical studies that blocking the expression of ... halts the development and progression of liver cancer ...
Breaking Medicine News(10 mins):Health News:Sports Nutrition Brand, Royal Sport LTD, Introduces 'Clean,' Gluten Free Protein Supplement, Royal Sport Ultra Clean 100™ 2Health News:ADOMANI Announces Jim Reynolds to Take Over as President and CEO 2Health News:Protean wins Airbus Helicopters Vision Zero Aviation Safety Award 2Health News:Protean wins Airbus Helicopters Vision Zero Aviation Safety Award 3Health News:Protean wins Airbus Helicopters Vision Zero Aviation Safety Award 4Health News:Study uncovers genetic driver of inflammation, uses it to prevent and treat liver cancer 2
(Date:9/22/2014)... image burn in Khabarovsk Krai, a territory occupying the coastline ... by plumes of smoke mark active fires. The smoke, which ... the Sea of Okhotsk. Taiga and tundra are ... the central depression, and deciduous forests are the natural vegetation ... Russia in the summer, the 2014 wildfire season appears to ...
(Date:9/22/2014)... could be much more useful in homes, if they ... see the world with cameras and lasers, which have ... are hidden in clutter. A complementary way robots can ... of small ultra-high frequency radio-frequency identification (UHF RFID) tags. ... an RFID-equipped robot to search a room for the ...
(Date:9/22/2014)... greater risk for stress-related diseases like type 2 ... new study by Brandeis University. , It,s long ... similar to the effects of illness or injury, ... part of our body,s healing response, runaway inflammation ... , In a recently published paper in ...
Breaking Biology News(10 mins):New RFID technology helps robots find household objects 2New RFID technology helps robots find household objects 3Obesity and stress pack a double hit for health 2
Other Contents